Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 35 | ECE2014 | Next issue

16th European Congress of Endocrinology

Symposia

Endocrine disease during pregnancy

ea0035s18.1 | Endocrine disease during pregnancy | ECE2014

Pituitary tumours during pregnancy

Mezosi Emese

The morphology and function of pituitary gland are significantly altered in pregnancy. Complex changes can be seen at the level of pituitary and target hormones, binding globulins and the effect of placental hormones are also should be taken into consideration; this makes the diagnosis of pituitary dysfunction more complicated than in the non-pregnant stage. The incidence of pituitary adenomas in child-bearing age is 0.93/100 000. All pituitary tumors carry an increased risk f...

ea0035s18.2 | Endocrine disease during pregnancy | ECE2014

Pheochromocytoma/paraganglioma in pregnancy

Mannelli Massimo

The occurrence of a pheochromocytoma (Pheo) or a paraganglioma (PGL) during pregnancy is extremely rare with a frequency of 0.002% of all pregnancies.Because of the rarity of this association and the extremely variable clinical picture of Pheo/PGL, the diagnosis constitutes a real challenge for the clinicians. In fact, the differential diagnosis between Pheo/PGL and the more frequent gestational hypertension or (pre)eclampsia is very difficult. Paroxysma...

ea0035s18.3 | Endocrine disease during pregnancy | ECE2014

Congenital adrenal hyperplasia in pregnancy

Hagenfeldt Kerstin

Congenital adrenal hyperplasia (CAH), with an autosomal recessive inheritance, is characterized by impaired or absent activity of one of the enzymes required for the biosynthesis of cortisol. In about 95%, CAH is due to mutations in the 21-hydroxylase gen (CYP21) and the lack of 21-hydroxylase results in a deficiency of cortisol, often also aldosterone and excess of androgens. The prenatal exposure of androgens virilise the female foetus in varying degrees depending on the lev...